Synthesis of 2-(2-adamantyl)piperidines and structure anti-influenza virus a activity relationship study using a combination of NMR spectroscopy and molecular modeling
Identifieur interne : 001984 ( Main/Exploration ); précédent : 001983; suivant : 001985Synthesis of 2-(2-adamantyl)piperidines and structure anti-influenza virus a activity relationship study using a combination of NMR spectroscopy and molecular modeling
Auteurs : Antonios Kolocouris [Grèce] ; Dimitrios Tataridis [Grèce] ; George Fytas [Grèce] ; Thomas Mavromoustakos [Grèce] ; George B. Foscolos [Grèce] ; Nicolas Kolocouris [Grèce] ; Erik De Clercq [Belgique]Source :
- Bioorganic & Medicinal Chemistry Letters [ 0960-894X ] ; 1999.
Descripteurs français
- KwdFr :
- MESH :
- pharmacologie : Antiviraux, Pipéridines.
- synthèse chimique : Antiviraux, Pipéridines.
- Pascal (Inist)
- Adamantane dérivé, Animaux, Antiviral, Antiviraux, Chiens, Composé saturé, Composé tricyclique, Hétérocycle azote, In vitro, Influenzavirus A, Influenzavirus B, Lignée cellulaire, Modèle moléculaire, Modèles moléculaires, Modélisation, Pipéridine(2-[2-adamantyl]), Pipéridine(2-[2-adamantyl]-1-alkyl), Pipéridines, Relation structure activité, Spectroscopie par résonance magnétique, Synthèse chimique, Virus de la grippe A.
English descriptors
- KwdEn :
- Animals, Antiviral, Antiviral Agents (chemical synthesis), Antiviral Agents (chemistry), Antiviral Agents (pharmacology), Cell Line, Chemical synthesis, Dogs, In vitro, Influenza A virus (drug effects), Influenzavirus A, Influenzavirus B, Magnetic Resonance Spectroscopy, Modeling, Models, Molecular, Molecular model, Nitrogen heterocycle, Piperidines (chemical synthesis), Piperidines (chemistry), Piperidines (pharmacology), Saturated compound, Structure activity relation, Tricyclic compound.
- MESH :
- chemical , chemical synthesis : Antiviral Agents, Piperidines.
- chemical , chemistry : Antiviral Agents, Piperidines.
- chemical , pharmacology : Antiviral Agents, Piperidines.
- drug effects : Influenza A virus.
- Animals, Cell Line, Dogs, Magnetic Resonance Spectroscopy, Models, Molecular.
- Teeft :
- Adamantane, Adamantane nucleus, Amantadine, Aminoadamantane heterocycles, Axial, Axial orientation, Biological activity, Bioorg, Chem, Clercq, Computational, Computational chemistry, Conformational, Conformational properties, Conformer, Conformers, Derivative, Energy conformers, Force field, Fytas, Heterocycle, Influenza, Influenza virus, Kolocouris, Lett, Parent piperidine, Pharmaceutical chemistry, Piperidine, Piperidine heterocycle, Piperidine heterocycles, Piperidines, Rimantadine.
Abstract
Abstract: The 2-(2-adamantyl)piperidines 13 and 15a-c were synthesized and evaluated for anti-influenza virus A and B activity. The parent N-H compound 13 was 3–4 times more active than amantadine and rimantadine against H2N2 influenza A. N-alkylation of 13 resulted in derivatives 15a-c that were devoid of biological activity. This dramatic reduction in biological activity may be attributed to the different conformational properties between N-H and N-alkyl piperidines, as deduced from the combination of computational chemistry and NMR spectroscopy.
2-(2-Adamantyl)piperidine 13 proved active against H2N2 influenza virus A. N-Alkylation resulted in inactive compounds 15a-c. This dramatic loss of activity could be attributed to comformational changes as indicated by computational analysis and NMR spectroscopy.gr1
Url:
DOI: 10.1016/S0960-894X(99)00631-9
Affiliations:
- Belgique, Grèce
- Attique (région), Province du Brabant flamand, Région flamande
- Athènes, Louvain
- Katholieke Universiteit Leuven
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000097
- to stream Istex, to step Curation: 000097
- to stream Istex, to step Checkpoint: 000784
- to stream Main, to step Merge: 001A31
- to stream PascalFrancis, to step Corpus: 000073
- to stream PascalFrancis, to step Curation: 000001
- to stream PascalFrancis, to step Checkpoint: 000073
- to stream Main, to step Merge: 001A86
- to stream PubMed, to step Corpus: 000371
- to stream PubMed, to step Curation: 000371
- to stream PubMed, to step Checkpoint: 000335
- to stream Ncbi, to step Merge: 000013
- to stream Ncbi, to step Curation: 000013
- to stream Ncbi, to step Checkpoint: 000013
- to stream Main, to step Merge: 001A13
- to stream Main, to step Curation: 001984
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Synthesis of 2-(2-adamantyl)piperidines and structure anti-influenza virus a activity relationship study using a combination of NMR spectroscopy and molecular modeling</title>
<author><name sortKey="Kolocouris, Antonios" sort="Kolocouris, Antonios" uniqKey="Kolocouris A" first="Antonios" last="Kolocouris">Antonios Kolocouris</name>
</author>
<author><name sortKey="Tataridis, Dimitrios" sort="Tataridis, Dimitrios" uniqKey="Tataridis D" first="Dimitrios" last="Tataridis">Dimitrios Tataridis</name>
</author>
<author><name sortKey="Fytas, George" sort="Fytas, George" uniqKey="Fytas G" first="George" last="Fytas">George Fytas</name>
</author>
<author><name sortKey="Mavromoustakos, Thomas" sort="Mavromoustakos, Thomas" uniqKey="Mavromoustakos T" first="Thomas" last="Mavromoustakos">Thomas Mavromoustakos</name>
</author>
<author><name sortKey="Foscolos, George B" sort="Foscolos, George B" uniqKey="Foscolos G" first="George B." last="Foscolos">George B. Foscolos</name>
</author>
<author><name sortKey="Kolocouris, Nicolas" sort="Kolocouris, Nicolas" uniqKey="Kolocouris N" first="Nicolas" last="Kolocouris">Nicolas Kolocouris</name>
</author>
<author><name sortKey="De Clercq, Erik" sort="De Clercq, Erik" uniqKey="De Clercq E" first="Erik" last="De Clercq">Erik De Clercq</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:9E203D1EE7819044016F00059E60F2B490E4BD85</idno>
<date when="1999" year="1999">1999</date>
<idno type="doi">10.1016/S0960-894X(99)00631-9</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-XKWTW4WL-N/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000097</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000097</idno>
<idno type="wicri:Area/Istex/Curation">000097</idno>
<idno type="wicri:Area/Istex/Checkpoint">000784</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000784</idno>
<idno type="wicri:doubleKey">0960-894X:1999:Kolocouris A:synthesis:of:adamantyl</idno>
<idno type="wicri:Area/Main/Merge">001A31</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:00-0080043</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000073</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000001</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000073</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000073</idno>
<idno type="wicri:doubleKey">0960-894X:1999:Kolocouris A:synthesis:of:adamantyl</idno>
<idno type="wicri:Area/Main/Merge">001A86</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:10617092</idno>
<idno type="wicri:Area/PubMed/Corpus">000371</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000371</idno>
<idno type="wicri:Area/PubMed/Curation">000371</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000371</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000335</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000335</idno>
<idno type="wicri:Area/Ncbi/Merge">000013</idno>
<idno type="wicri:Area/Ncbi/Curation">000013</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000013</idno>
<idno type="wicri:doubleKey">0960-894X:1999:Kolocouris A:synthesis:of:adamantyl</idno>
<idno type="wicri:Area/Main/Merge">001A13</idno>
<idno type="wicri:Area/Main/Curation">001984</idno>
<idno type="wicri:Area/Main/Exploration">001984</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a">Synthesis of 2-(2-adamantyl)piperidines and structure anti-influenza virus a activity relationship study using a combination of NMR spectroscopy and molecular modeling</title>
<author><name sortKey="Kolocouris, Antonios" sort="Kolocouris, Antonios" uniqKey="Kolocouris A" first="Antonios" last="Kolocouris">Antonios Kolocouris</name>
<affiliation wicri:level="3"><country xml:lang="fr">Grèce</country>
<wicri:regionArea>National Hellenic Research Foundation, Institute of Organic and Pharmaceutical Chemistry, Vas. Constantinou 48, 11635, Athens</wicri:regionArea>
<placeName><settlement type="city">Athènes</settlement>
<region nuts="2" type="region">Attique (région)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Tataridis, Dimitrios" sort="Tataridis, Dimitrios" uniqKey="Tataridis D" first="Dimitrios" last="Tataridis">Dimitrios Tataridis</name>
<affiliation wicri:level="1"><country xml:lang="fr">Grèce</country>
<wicri:regionArea>Department of Pharmacy, Division of Pharmaceutical Chemistry, University of Athens, Panepistimioupoli-Zografou, GR-15771 Athens</wicri:regionArea>
<wicri:noRegion>GR-15771 Athens</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Fytas, George" sort="Fytas, George" uniqKey="Fytas G" first="George" last="Fytas">George Fytas</name>
<affiliation wicri:level="1"><country xml:lang="fr">Grèce</country>
<wicri:regionArea>Department of Pharmacy, Division of Pharmaceutical Chemistry, University of Athens, Panepistimioupoli-Zografou, GR-15771 Athens</wicri:regionArea>
<wicri:noRegion>GR-15771 Athens</wicri:noRegion>
</affiliation>
<affiliation></affiliation>
<affiliation wicri:level="1"><country wicri:rule="url">Grèce</country>
</affiliation>
</author>
<author><name sortKey="Mavromoustakos, Thomas" sort="Mavromoustakos, Thomas" uniqKey="Mavromoustakos T" first="Thomas" last="Mavromoustakos">Thomas Mavromoustakos</name>
<affiliation wicri:level="3"><country xml:lang="fr">Grèce</country>
<wicri:regionArea>National Hellenic Research Foundation, Institute of Organic and Pharmaceutical Chemistry, Vas. Constantinou 48, 11635, Athens</wicri:regionArea>
<placeName><settlement type="city">Athènes</settlement>
<region nuts="2" type="region">Attique (région)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Foscolos, George B" sort="Foscolos, George B" uniqKey="Foscolos G" first="George B." last="Foscolos">George B. Foscolos</name>
<affiliation wicri:level="1"><country xml:lang="fr">Grèce</country>
<wicri:regionArea>Department of Pharmacy, Division of Pharmaceutical Chemistry, University of Athens, Panepistimioupoli-Zografou, GR-15771 Athens</wicri:regionArea>
<wicri:noRegion>GR-15771 Athens</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kolocouris, Nicolas" sort="Kolocouris, Nicolas" uniqKey="Kolocouris N" first="Nicolas" last="Kolocouris">Nicolas Kolocouris</name>
<affiliation wicri:level="1"><country xml:lang="fr">Grèce</country>
<wicri:regionArea>Department of Pharmacy, Division of Pharmaceutical Chemistry, University of Athens, Panepistimioupoli-Zografou, GR-15771 Athens</wicri:regionArea>
<wicri:noRegion>GR-15771 Athens</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="De Clercq, Erik" sort="De Clercq, Erik" uniqKey="De Clercq E" first="Erik" last="De Clercq">Erik De Clercq</name>
<affiliation wicri:level="4"><country xml:lang="fr">Belgique</country>
<wicri:regionArea>Rega Institute for Medical Research, Katholieke Universiteit Leuven, B-3000 Leuven</wicri:regionArea>
<orgName type="university">Katholieke Universiteit Leuven</orgName>
<placeName><settlement type="city">Louvain</settlement>
<region>Région flamande</region>
<region type="district" nuts="2">Province du Brabant flamand</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Bioorganic & Medicinal Chemistry Letters</title>
<title level="j" type="abbrev">BMCL</title>
<idno type="ISSN">0960-894X</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="1999">1999</date>
<biblScope unit="volume">9</biblScope>
<biblScope unit="issue">24</biblScope>
<biblScope unit="page" from="3465">3465</biblScope>
<biblScope unit="page" to="3470">3470</biblScope>
</imprint>
<idno type="ISSN">0960-894X</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0960-894X</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Antiviral</term>
<term>Antiviral Agents (chemical synthesis)</term>
<term>Antiviral Agents (chemistry)</term>
<term>Antiviral Agents (pharmacology)</term>
<term>Cell Line</term>
<term>Chemical synthesis</term>
<term>Dogs</term>
<term>In vitro</term>
<term>Influenza A virus (drug effects)</term>
<term>Influenzavirus A</term>
<term>Influenzavirus B</term>
<term>Magnetic Resonance Spectroscopy</term>
<term>Modeling</term>
<term>Models, Molecular</term>
<term>Molecular model</term>
<term>Nitrogen heterocycle</term>
<term>Piperidines (chemical synthesis)</term>
<term>Piperidines (chemistry)</term>
<term>Piperidines (pharmacology)</term>
<term>Saturated compound</term>
<term>Structure activity relation</term>
<term>Tricyclic compound</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term>
<term>Antiviraux ()</term>
<term>Antiviraux (pharmacologie)</term>
<term>Antiviraux (synthèse chimique)</term>
<term>Chiens</term>
<term>Lignée cellulaire</term>
<term>Modèles moléculaires</term>
<term>Pipéridines ()</term>
<term>Pipéridines (pharmacologie)</term>
<term>Pipéridines (synthèse chimique)</term>
<term>Spectroscopie par résonance magnétique</term>
<term>Virus de la grippe A ()</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemical synthesis" xml:lang="en"><term>Antiviral Agents</term>
<term>Piperidines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Antiviral Agents</term>
<term>Piperidines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Antiviral Agents</term>
<term>Piperidines</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Influenza A virus</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Antiviraux</term>
<term>Pipéridines</term>
</keywords>
<keywords scheme="MESH" qualifier="synthèse chimique" xml:lang="fr"><term>Antiviraux</term>
<term>Pipéridines</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Cell Line</term>
<term>Dogs</term>
<term>Magnetic Resonance Spectroscopy</term>
<term>Models, Molecular</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Adamantane dérivé</term>
<term>Animaux</term>
<term>Antiviral</term>
<term>Antiviraux</term>
<term>Chiens</term>
<term>Composé saturé</term>
<term>Composé tricyclique</term>
<term>Hétérocycle azote</term>
<term>In vitro</term>
<term>Influenzavirus A</term>
<term>Influenzavirus B</term>
<term>Lignée cellulaire</term>
<term>Modèle moléculaire</term>
<term>Modèles moléculaires</term>
<term>Modélisation</term>
<term>Pipéridine(2-[2-adamantyl])</term>
<term>Pipéridine(2-[2-adamantyl]-1-alkyl)</term>
<term>Pipéridines</term>
<term>Relation structure activité</term>
<term>Spectroscopie par résonance magnétique</term>
<term>Synthèse chimique</term>
<term>Virus de la grippe A</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en"><term>Adamantane</term>
<term>Adamantane nucleus</term>
<term>Amantadine</term>
<term>Aminoadamantane heterocycles</term>
<term>Axial</term>
<term>Axial orientation</term>
<term>Biological activity</term>
<term>Bioorg</term>
<term>Chem</term>
<term>Clercq</term>
<term>Computational</term>
<term>Computational chemistry</term>
<term>Conformational</term>
<term>Conformational properties</term>
<term>Conformer</term>
<term>Conformers</term>
<term>Derivative</term>
<term>Energy conformers</term>
<term>Force field</term>
<term>Fytas</term>
<term>Heterocycle</term>
<term>Influenza</term>
<term>Influenza virus</term>
<term>Kolocouris</term>
<term>Lett</term>
<term>Parent piperidine</term>
<term>Pharmaceutical chemistry</term>
<term>Piperidine</term>
<term>Piperidine heterocycle</term>
<term>Piperidine heterocycles</term>
<term>Piperidines</term>
<term>Rimantadine</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Abstract: The 2-(2-adamantyl)piperidines 13 and 15a-c were synthesized and evaluated for anti-influenza virus A and B activity. The parent N-H compound 13 was 3–4 times more active than amantadine and rimantadine against H2N2 influenza A. N-alkylation of 13 resulted in derivatives 15a-c that were devoid of biological activity. This dramatic reduction in biological activity may be attributed to the different conformational properties between N-H and N-alkyl piperidines, as deduced from the combination of computational chemistry and NMR spectroscopy.</div>
<div type="abstract">2-(2-Adamantyl)piperidine 13 proved active against H2N2 influenza virus A. N-Alkylation resulted in inactive compounds 15a-c. This dramatic loss of activity could be attributed to comformational changes as indicated by computational analysis and NMR spectroscopy.gr1 </div>
</front>
</TEI>
<affiliations><list><country><li>Belgique</li>
<li>Grèce</li>
</country>
<region><li>Attique (région)</li>
<li>Province du Brabant flamand</li>
<li>Région flamande</li>
</region>
<settlement><li>Athènes</li>
<li>Louvain</li>
</settlement>
<orgName><li>Katholieke Universiteit Leuven</li>
</orgName>
</list>
<tree><country name="Grèce"><region name="Attique (région)"><name sortKey="Kolocouris, Antonios" sort="Kolocouris, Antonios" uniqKey="Kolocouris A" first="Antonios" last="Kolocouris">Antonios Kolocouris</name>
</region>
<name sortKey="Foscolos, George B" sort="Foscolos, George B" uniqKey="Foscolos G" first="George B." last="Foscolos">George B. Foscolos</name>
<name sortKey="Fytas, George" sort="Fytas, George" uniqKey="Fytas G" first="George" last="Fytas">George Fytas</name>
<name sortKey="Fytas, George" sort="Fytas, George" uniqKey="Fytas G" first="George" last="Fytas">George Fytas</name>
<name sortKey="Kolocouris, Nicolas" sort="Kolocouris, Nicolas" uniqKey="Kolocouris N" first="Nicolas" last="Kolocouris">Nicolas Kolocouris</name>
<name sortKey="Mavromoustakos, Thomas" sort="Mavromoustakos, Thomas" uniqKey="Mavromoustakos T" first="Thomas" last="Mavromoustakos">Thomas Mavromoustakos</name>
<name sortKey="Tataridis, Dimitrios" sort="Tataridis, Dimitrios" uniqKey="Tataridis D" first="Dimitrios" last="Tataridis">Dimitrios Tataridis</name>
</country>
<country name="Belgique"><region name="Région flamande"><name sortKey="De Clercq, Erik" sort="De Clercq, Erik" uniqKey="De Clercq E" first="Erik" last="De Clercq">Erik De Clercq</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001984 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001984 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= H2N2V1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:9E203D1EE7819044016F00059E60F2B490E4BD85 |texte= Synthesis of 2-(2-adamantyl)piperidines and structure anti-influenza virus a activity relationship study using a combination of NMR spectroscopy and molecular modeling }}
This area was generated with Dilib version V0.6.33. |